A comparison of charlson and elixhauser comorbidity measures to predict colorectal cancer survival using administrative health data

Cancer

Volumn 117, Issue 9, 2011, Pages 1957-1965

  Lieffers, Jessica R ^a   Baracos, Vickie E ^a   Winget, Marcy ^a,b   Fassbender, Konrad ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ALBERTA HEALTH SERVICES   (Canada)

Author keywords

administrative health data; Charlson comorbidity index; colorectal cancer; comorbidity; Elixhauser comorbidity method; risk adjustment; survival

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CEREBROVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; CHRONIC LUNG DISEASE; COLORECTAL CANCER; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; ELIXHAUSER COMORBIDITY METHOD; FEMALE; HEART INFARCTION; HUMAN; KIDNEY DISEASE; LENGTH OF STAY; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; OVERALL SURVIVAL; PEPTIC ULCER; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SURVIVAL RATE; WEIGHT REDUCTION;

AGED; COLORECTAL NEOPLASMS; COMORBIDITY; FEMALE; FORECASTING; HUMANS; MALE; MIDDLE AGED; RISK ADJUSTMENT;

EID: 79955436266     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25653     Document Type: Article

References (41)

1. Hines RB, Shanmugam C, Waterbor JW, et al. Effect of comorbidity and body mass index on the survival of African-American and Caucasian patients with colon cancer. Cancer. 2009; 115: 5798-5806.
2. Iversen LH, Norgaard M, Jacobsen J, Laurberg S, Sorensen HT., The impact of comorbidity on survival of Danish colorectal cancer patients from 1995 to 2006-a population-based cohort study. Dis Colon Rectum. 2009; 52: 71-78.
3. Lemmens VE, Janssen-Heijnen ML, Verheij CD, Houterman S, Repelaer van Driel OJ, Coebergh JW., Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg. 2005; 92: 615-623. (Pubitemid 40685658)
4. Gross CP, Guo Z, McAvay GJ, Allore HG, Young M, Tinetti ME., Multimorbidity and survival in older persons with colorectal cancer. J Am Geriatr Soc. 2006; 54: 1898-1904. (Pubitemid 44915834)
5. Extermann M, Overcash J, Lyman GH, Parr J, Balducci L., Comorbidity and functional status are independent in older cancer patients. J Clin Oncol. 1998; 16: 1582-1587. (Pubitemid 28175784)
6. De Marco MF, Janssen-Heijnen ML, van der Heijden LH, Coebergh JW., Comorbidity and colorectal cancer according to subsite and stage: a population-based study. Eur J Cancer. 2000; 36: 95-99. (Pubitemid 30035350)
7. Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med. 1980; 69: 491-497. (Pubitemid 10018703)
8. Kalantar-Zadeh K, Horwich TB, Oreopoulos A, et al. Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care. 2007; 10: 433-442. (Pubitemid 46934112)
9. Charlson ME, Pompei P, Ales KL, MacKenzie CR., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373-383. (Pubitemid 17055592)
10. Elixhauser A, Steiner C, Harris DR, Coffey RM., Comorbidity measures for use with administrative data. Med Care. 1998; 36: 8-27. (Pubitemid 128456396)
11. Southern DA, Quan H, Ghali WA., Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data. Med Care. 2004; 42: 355-360.
12. Stukenborg GJ, Wagner DP, Connors AF Jr., Comparison of the performance of two comorbidity measures, with and without information from prior hospitalizations. Med Care. 2001; 39: 727-739. (Pubitemid 33610097)
13. Dominick KL, Dudley TK, Coffman CJ, Bosworth HB., Comparison of three comorbidity measures for predicting health service use in patients with osteoarthritis. Arthritis Rheum. 2005; 53: 666-672. (Pubitemid 41463830)
14. Baldwin LM, Klabunde CN, Green P, Barlow W, Wright G., In search of the perfect comorbidity measure for use with administrative claims data: Does it exist? Med Care. 2006; 44: 745-753. (Pubitemid 44284265)
15. Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006; 355: 763-778. (Pubitemid 44285582)
16. Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC., Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol. 2004; 43: 1439-1444. (Pubitemid 38496352)
17. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB., Survival advantages of obesity in dialysis patients. Am J Clin Nutr. 2005; 81: 543-554.
18. Fritz A, Percy C, Jack A, et al, eds. International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
19. Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumours. 6th ed. New York: Wiley-Liss; 2002.
20. Ottery FD,. Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition. 1996; 12: S15-S19.
21. Perry GS, Byers TE, Mokdad AH, Serdula MK, Williamson DF., The validity of self-reports of past body weights by U.S. adults. Epidemiology. 1995; 6: 61-66.
22. Stunkard AJ, Albaum JM., The accuracy of self-reported weights. Am J Clin Nutr. 1981; 34: 1593-1599.
23. Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008; 9: 629-635.
24. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005; 43: 1130-1139. (Pubitemid 41587600)
25. Dignam JJ, Polite BN, Yothers G, et al. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst. 2006; 98: 1647-1654. (Pubitemid 44811647)
26. Meyerhardt JA, Tepper JE, Niedzwiecki D, et al. Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from intergroup trial 0114. J Clin Oncol. 2004; 22: 648-657. (Pubitemid 41095068)
27. Evans WJ, Morley JE, Argiles J, et al. Cachexia: a new definition. Clin Nutr. 2008; 27: 793-799.
28. McNutt LA, Wu C, Xue X, Hafner JP., Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol. 2003; 157: 940-943. (Pubitemid 36555054)
29. Deddens JA, Petersen MR., Approaches for estimating prevalence ratios. Occup Environ Med. 2008; 65: 501-506. (Pubitemid 351969703)
30. Chen H, Cohen P, Chen S., Biased odds ratios from dichotomization of age. Stat Med. 2007; 26: 3487-3497. (Pubitemid 47162005)
31. Cleves MA., From the help desk: comparing areas under receiver operating characteristic curves from two or more probit or logit models. Stata J. 2002; 2: 301-313.
32. DeLong ER, DeLong DM, Clarke-Pearson DL., Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988; 44: 837-845.
33. Harrell FE Jr, Lee KL, Califf RM, Pryor DB, Rosati RA., Regression modelling strategies for improved prognostic prediction. Stat Med. 1984; 3: 143-152. (Pubitemid 14052973)
34. Hosmer DW, Lemeshow S., Applied Logistic Regression. 2nd ed. New York: John Wiley & Sons, Inc.; 2000.
35. Gould MK, Ananth L, Barnett PG, Veterans Affairs SNAP Cooperative Study Group. A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules. Chest. 2007; 131: 383-388. (Pubitemid 46280396)
36. van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ., A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009; 47: 626-633.
37. Sundararajan V, Quan H, Halfon P, et al. Cross-national comparative performance of three versions of the ICD-10 Charlson index. Med Care. 2007; 45: 1210-1215.
38. Li B, Evans D, Faris P, Dean S, Quan H., Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases. BMC Health Serv Res. 2008; 8: 12.
39. Read WL, Tierney RM, Page NC, et al. Differential prognostic impact of comorbidity. J Clin Oncol. 2004; 22: 3099-3103. (Pubitemid 41103722)
40. Johnston JA, Wagner DP, Timmons S, Welsh D, Tsevat J, Render ML., Impact of different measures of comorbid disease on predicted mortality of intensive care unit patients. Med Care. 2002; 40: 929-940.
41. Woo JG, Zeller MH, Wilson K, Inge T., Obesity identified by discharge ICD-9 codes underestimates the true prevalence of obesity in hospitalized children. J Pediatr. 2009; 154: 327-331.